A meta analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graft

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zhang, Haifei ^a   Wang, Feng ^a   Ding, Lin ^a   Zhang, Zhiyu ^a   Sun, Deri ^a   Feng, Xinmin ^a   An, Jiuli ^a   Zhu, Yue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; OSTEOGENIC PROTEIN 1;

ARTICLE; BONE GRAFT; HUMAN; ILIAC CREST; INTERMETHOD COMPARISON; LENGTH OF STAY; LUMBAR SPINAL FUSION SURGERY; META ANALYSIS; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; RISK ASSESSMENT; SPINE DISEASE; SPINE SURGERY; SYSTEMATIC REVIEW; ADULT; AGED; AUTOTRANSPLANTATION; BONE TRANSPLANTATION; FEMALE; ILIAC BONE; LUMBAR VERTEBRA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PUBLISHING; RETURN TO WORK; SPINE FUSION; STATISTICS AND NUMERICAL DATA; SURGERY; TRANSPLANTATION;

ADULT; AGED; BLOOD LOSS, SURGICAL; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; FEMALE; HUMANS; ILIUM; LENGTH OF STAY; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OPERATIVE TIME; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATIONS; PUBLICATION BIAS; REOPERATION; RETURN TO WORK; SPINAL FUSION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84902352357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097049     Document Type: Article

References (53)

1. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA (1996) Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329: 300-309. doi:10.1097/00003086-199608000-00037. (Pubitemid 26274684)
2. Urist MR (1965) Bone Formation by autoinduction. Science 150: 893-899. doi:10.1126/science.150.3698.893.
3. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, et al. (1990) Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87: 9843-9847. doi:10.1073/pnas.87.24.9843. (Pubitemid 120016540)
4. Landis JR,Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174. doi:10.2307/2529310. (Pubitemid 8054849)
5. Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic.Fam Med 37: 360-363. (Pubitemid 40656185)
6. Furlan AD, Pennick V, Bombardier C, van Tulder M (2009) 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine. doi:10.1097/BRS.0b013e3181b1c99f.
7. Higgins JPT, Green S (2008) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1[updated September 2008]. The Cochrane Collaboration.
8. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. (Pubitemid 17189972)
9. Egger M, Smith GD, Schneider M, Minder C (2000) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. doi:10.1136/bmj.315. 7109.629. (Pubitemid 27387172)
10. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101. doi:10.2307/2533446.
11. Egger M, Smith GD (1998) Bias in location and selection of studies. BMJ 316: 61-66. doi:10.1136/bmj.316.7124.61.
12. Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463. doi:10.1111/j.0006-341X.2000.00455.x. (Pubitemid 30422636)
13. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR (2000) Empirical assessment of effect of publication bias on meta-analyses. BMJ 320: 1574-1577. doi:10.1136/bmj.320.7249.1574. (Pubitemid 30336090)
14. Boden SD, Zdeblick TA, Sandhu HS, Heim SE (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25: 376-381. doi:10.1097/00007632-200002010-00020. (Pubitemid 30097051)
15. Boden SD, Kang J, Sandhu H, Heller JG (2002) Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27: 2662-2673. doi:10.1097/00007632-200212010-00005. (Pubitemid 35425320)
16. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA (2002) Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15: 337-349. doi:10.1097/00024720-200210000-00001.
17. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA (2002) Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 27: 2396-2408. doi:10.1097/00007632-200211010-00015. (Pubitemid 35266228)
18. Johnsson R, Strömqvist B, Aspenberg P (2002) Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies. spine 27: 2654-2661. doi:10.1097/00007632-200212010-00004.
19. Burkus JK, Dorchak JD, Sanders DL (2003) Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine 28: 372-377. doi:10.1097/01.BRS. 0000048469.45035.B9.
20. Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK (2004) Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 4: 527-538. doi:10.1016/j.spinee.2004.03. 025. (Pubitemid 40029169)
21. Assiri I, du Plessis S, Hurlbert J, Hu R, Salo P, et al. (2004) A prospective randomized clinical study comparing instrumented lumbar fusion rates of Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2) with autogenous iliac crest bone graft in patients with symptomatic degenerative disc disease. Canadian Journal of Surgery (Suppl 4): 7-8.
22. Glassman SD, Dimar JR, Carreon LY, Campbell MJ, Puno RM, et al. (2005) Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion. Spine 30: 1694-1698. doi:10.1097/01. brs.0000172157.39513.80.
23. Vaccaro AR, Anderson DG, Patel T, Fischgrund J, Truumees E, et al. (2005) Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine 30: 2709-2716. doi:10.1097/01.brs.0000190812.08447.ba. (Pubitemid 43011029)
24. Burkus JK, Sandhu HS, Gornet MF, Lonely MC (2005) Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 87: 1205-1212. doi:10.2106/JBJS.D.02532.
25. Dimar JR, Glassman SD, Burkus KJ, Carreon LY (2006) Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 31: 2534-2539. doi:10.1097/01.brs. 0000240715.78657.81. (Pubitemid 44632234)
26. Kanayama M, Hashimoto T, Shigenobu K, Yamane S, Bauer TW, et al. (2006) A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. Spine 31: 1067-1074. doi:10.1097/01.brs.0000216444.01888.21.
27. Glassman SD, Carreon LY, Djurasovic M, Campbell MJ, Puno RM, et al. (2008) RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over 60 years of age. Spine 33: 2843-2849. doi:10.1097/BRS.0b013e318190705d.
28. Vaccaro AR, Lawrence JP, Patel T, Katz LD, Anderson DG, et al. (2008) The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study. Spine 33: 2850-2862. doi:10.1097/BRS.0b013e31818a314d.
29. Dimar JR 2nd, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, et al. (2009) Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. Journal Bone Joint Surg Am 91: 1377-1386. doi:10.2106/JBJS.H.00200.
30. Dawson E, Bae HW, Burkus JK, Stambough JL, Glassman SD (2009) Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am 91: 1604-1613. doi:10.2106/JBJS.G.01157.
31. Delawi D, Dhert WJ, Rillardon L, Gay E, Prestamburgo D, et al. (2010) A prospective, randomized, controlled, multicenter study of osteogenic protein-1 in instrumented posterolateral fusions: report on safety and feasibility. Spine 35: 1185-1191. doi:10.1097/BRS.0b013e3181d3cf28.
32. Michielsen J, Sys J, Rigaux A, Bertrand C (2013) The effect of recombinant human bone morphogenetic protein-2 in single-level posteriorlumbar interbody arthrodesis. J Bone Joint Surg Am 95: 873-880. doi:10.2106/JBJS.L. 00137.
33. An H, Boden SD, Kang J, Sandhu HS, Abdu W, et al. (2003) Summary statement: emerging techniques for treatment of degenerative lumbar disc disease. Spine 28: S24-S25. doi:10.1097/01.BRS.0000076894.33269.19. (Pubitemid 36959579)
34. Younger EM, Chapman MW (1989) Morbidity at bone graft donor sites. J Orthop Trauma 3: 192-195. doi:10.1097/00005131-198909000-00002.
35. Banwart JC, Asher MA, Hassanein RS (1995) Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine 20: 1055-1060. doi:10.1097/00007632-199505000-00012.
36. Hutchinson MR, Dall BE (1994) Midline fascial splitting approach to the iliac crest for bone graft: a new approach. Spine 19: 62-66. doi:10.1097/00007632-199401000-00013. (Pubitemid 24039183)
37. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P (2002) Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 84: 716-720.
38. Sen MK, Miclau T (2007) Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? Injury 38 Suppl 1: S75-80.doi:10.1016/j.injury.2007.02.012. (Pubitemid 46440932)
39. Reddi AH (1998) Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechno 16: 247-252. doi:10.1038/nbt0398- 247.
40. Dimitriou R, Tsiridis E, Giannoudis PV (2005) Current concepts of molecular aspects of bone healing. Injury 36: 1392-1404. doi:/10.1016/j.injury. 2005.07.019.
41. Poynton AR, Lane JM (2002) Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27: S40-48. doi:10.1097/00007632- 200208151-00010.
42. Benglis D, Wang MY, Levi AD (2008) A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 62: ONS423-431; discussion ONS431. doi:10.1227/01.neu.0000326030.24220.d8.
43. Carragee EJ,Hurwitz EL, Weiner BK (2011) A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11: 471-491. doi:10.1016/j.spinee.2011.04. 023.
44. Mussano F, Ciccone G, Ceccarelli M, Baldi I, Bassi F (2007) Bone morphogenetic proteins and bone defects: a systematic review. Spine 32: 824-830. doi:10.1097/01.brs.0000259227.51180.ca. (Pubitemid 46573337)
45. Papakostidis C, Kontakis G, Bhandari M, Giannoudis PV (2008) Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results. Spine 33: E680-692. doi:10.1097/BRS.0b013e3181844eca.
46. Agarwal R, Williams K, Umscheid CA, Welch WC (2009) Osteoinductive bone graft substitutes for lumbar fusion: a systematic review. J Neurosurg Spine 11: 729-740. doi:10.3171/2009.6.SPINE08669.
47. Chen Z, Ba G, Shen T, Fu Q (2012) Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials. Arch Orthop Trauma Surg 132: 1725-1740. doi:10.1007/s00402-012-1607-3.
48. Donell S, Garrison K, Shemilt I, Song F (2011) Bone Morphogenetic Protein-2 for Spinal Fusion: Meta-analysis of Randomised Controlled Trials. UEA Website. Available:http://www.uea.ac.uk/~wo158/BMP-2%20for%20SF%20- %20Metaanalysis%20of%20RCTs.pdf. Accessed Dec 12, 2013.
49. Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, et al. (2013) Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann Intern Med. 158: 890-902. doi:10.7326/0003-4819-158-12-201306180-00006.
50. Simmonds MC, Brown JV, Heirs MK, Higgins JP, Mannion RJ, et al. (2013) Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med. 158: 877-889. doi:10.7326/0003-4819-158-12-201306180-00005.
51. Yale School of Medicine. Available: http://medicine.yale.edu/core/ projects/ yodap/datasharing/medtronic/463-158787-YorkrhBMP2FinalReport.pdf. Accessed Dec 12, 2013.
52. Blumenthal SL, Gill K (1993) Can lumbar spine radiographs accurately determine fusion in postoperative patients? Correlation of routine radiographs with a second surgical look at lumbar fusions.Spine18: 1186-1189. doi:10.1097/00007632-199307000-00010. (Pubitemid 23210768)
53. Mroz TE, Wang JC, Hashimoto R, Norvell DC (2010) Complications related to osteobiologics use in spine surgery: a systematic review. Spine 35: S86-104. doi:10.1097/BRS.0b013e3181d81ef2.